.jpg)
Sarfraz Thind takes a deep dive into how Covid-19 has distorted the market. In part one of this two part series he looks at commercial mortgage-backed securitisations (CMBS), collateralised loan obligation (CLO) and municipal bonds.
Insurance Asset Risk surveyed the industry to find out how it is rethinking asset allocation in the wake of COVID-19's impact on the economy and financial markets. Vincent Huck presents the results
Frank Schiller, board member of the DAV, tells David Walker in a far ranging interview his thoughts on the 2020 Solvency II review and where he believes EIOPA needs to step up its work.
.jpg)
As European regulators offer some leeway on Solvency II regulatory reporting deadlines, insurers seem inclined to follow the original schedule. Begging the question of how to account for the COVID-19 impact. David Walker reports
Could European underwriters have a thing or two to learn from their Chinese counterparts when it comes to transparency in their reporting? David Walker takes a closer look
With lower ratings than their developed market counterparts and potential economic dependencies to oil, emerging markets are on the frontline of the COVID-19 crisis. It is raising questions for insurers' allocation to the asset class. Vincent Huck reports
Jegor Tokarevich and Amirlan Seksenbayev from Substance Over Form, look at the risks posed by COVID-19 to insurance investors and how they can mitigate them to make the most of the opportunities arising.
Not a single day passes without some new market revelation. Insurers are battening down the hatches but how bad is it and what damage has there been so far? Sarfraz Thind presents the good, the bad and the ugly of the market crash.
As markets sink, a chief investment officer at a European insurer tells Vincent Huck how the pandemic is affecting its thinking.
Analysis by Insurance Risk Data shows most countries' underwriters were adding equities in general accounts as virus risk approached. David Walker reports
Half of the world's largest asset managers are neglecting the ecological and social harms of their investments, according to a research by ShareAction. However, insurers' affiliates seem to be ahead of the curve. Vincent Huck reports
Carlos Montalvo Rebuelta reflects on what we should expect from the Solvency II 2020 review based on past amendments of the Directive. So good or bad news?